| Tag | Content |
|---|
EnhancerAtlas ID | HS051-25875 |
Organism | Homo sapiens |
Tissue/cell | Fetal_thymus |
Coordinate | chr8:2094400-2095430 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CREB3 | MA0638.1 | chr8:2094554-2094568 | CTGACACGTCACCA | + | 6.78 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_12283 | chr8:2092526-2095308 | CD3 | | SE_20576 | chr8:2092461-2095726 | CD56 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr8 | 2094462 | 2094719 | | chr8 | 2094833 | 2095141 | | chr8 | 2095185 | 2095235 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH08I002144 | chr8 | 2092719 | 2095482 |
|
Enhancer Sequence | TTTAATAGAC CTCCTTTTTG AGCAGTTTTA GGTTCACAGC AAAGTTAAAA GGAAGGTAGA 60
GATCTCCACT CCAACCCCTA CCCCCACCAC AGCTTCCCCC GCTACCAACA CCTCCCACCA 120
GAGGGATGTG CTTGTTACAA CCGCTGCACC CACACTGACA CGTCACCATC CTCGCAGGCT 180
GGAGTTTACC CTGGGCTCGC TTCTGGCGCT TGTTACAACT GCTGCACCCA CACTGAAGCG 240
TCAGCATTGC CGGGGGCTGG AGTTTACCCT GGGCACACTC CTGGTGCTGT TGGCTCTGTG 300
GGTTTGGTCG GGTGATCAGG ACTCAGGTCC ACCATTGTAG CATCATGCAC AGTCTTTTCT 360
CTGCCCTAAA AATCTTCCCT TCAACCACTG AGCATTTTAC TGCCTCCATA GTTTTGAGTT 420
ATAATATTTT TTAAAAGACT TTTTTTTTAA AAGAATGAAA TAGTCTTAGA CATGCAGTAA 480
AGTGTCTTTA CAACGGCGCA GAGAGCCCAG TGGACTCCAC AGTCTTCCTG TTGTTCACGT 540
CTCGCGTTGC TGTGGGGCGA GACGATGGCC TCACCTCCAG GTGGCCTTCA GACCTTGCTG 600
GGTTCCCCCA ATGCCCTCTC TCTGTCCCAG GACCCATCGA GGACACCAGA TGAATTTGCT 660
GTTCACGTCT CCCAGCCCCT CCGTCCTGCG ATGGTTTCTG TCTGTCCTTG CCTTTCATGA 720
CCTTAGTGGC TTTGAGGAGT TTTGCTGGTT ATCTTGTAGG ATGTTCCCCA ATCCAGGTCC 780
CCAGTCCAGG GAAGACGATC TTCGTGTGAT GAGACTGGGG ATGTGTGCTT TTGGGAAGAG 840
GAGTCACGTG GGGTGCCCGA CATCCGCTAA CCTTCATCAC TTGCTCAGGT GATGTCTGCC 900
TGCTGTCTCC CATGAAATGC CTGCTTTTTC CTCTTCTCCT TCTATTCCTT GGGAGCCTGT 960
CTCAGCCCAG ACCACCCTCA AAGAAGCAAG AGCATGGAAT CACGTTCACC TCTTGGAGCA 1020
GGAGCATCTA 1030
|
